ProfessorsProfessors of University of California, Los AngelesJon Thomas Van Lew

Jon Thomas Van Lew

University of California, Los Angeles

H-index: 14

North America-United States

About Jon Thomas Van Lew

Jon Thomas Van Lew, With an exceptional h-index of 14 and a recent h-index of 11 (since 2020), a distinguished researcher at University of California, Los Angeles, specializes in the field of Energy, Fusion, Solar, Biotech.

His recent articles reflect a diverse array of research interests and contributions to the field:

Devices And Methods For Mitochondria Replacement And For Generating Cellular Therapeutics

Method of treatment of a tumor with il-8 antibody

Method of treatment of a tumor with an IL-8 antibody

Electroporation With Active Compensation

EMT PATH BLOCKING IINTERLEUKIN 8 AND CONTROLLING CARCINOUS STEM CELLS

Pressure-driven mitochondrial transfer pipeline generates mammalian cells of desired genetic combinations and fates

Anti-IL8 antibodies

Jon Thomas Van Lew Information

University	University of California, Los Angeles
Position	University of Arizona ImmunityBio
Citations(all)	923
Citations(since 2020)	376
Cited By	720
hIndex(all)	14
hIndex(since 2020)	11
i10Index(all)	14
i10Index(since 2020)	11
Email	Access Email
University Profile Page	University of California, Los Angeles
Google Scholar	View Google Scholar Profile

Jon Thomas Van Lew Skills & Research Interests

Energy

Fusion

Solar

Biotech

Top articles of Jon Thomas Van Lew

Title	Journal	Author(s)	Publication Date
Devices And Methods For Mitochondria Replacement And For Generating Cellular Therapeutics			2023/5/2
Method of treatment of a tumor with il-8 antibody			2023/12/21
Method of treatment of a tumor with an IL-8 antibody			2023/10/3
Electroporation With Active Compensation			2022/1/27
EMT PATH BLOCKING IINTERLEUKIN 8 AND CONTROLLING CARCINOUS STEM CELLS			2021/7/28
Pressure-driven mitochondrial transfer pipeline generates mammalian cells of desired genetic combinations and fates	Cell reports	Alexander N Patananan Alexander J Sercel Ting-Hsiang Wu Fasih M Ahsan Alejandro Torres ...	2020/12/29
Anti-IL8 antibodies			2020/8/25